Centene Corp (CNC.N)


CNC.N on New York Stock Exchange

51.56USD
19 Jun 2013
Price Change (% chg)

$-0.42 (-0.81%)
Prev Close
$51.98
Open
$51.99
Day's High
$52.00
Day's Low
$51.56
Volume
4,845
Avg. Vol
107,072
52-wk High
$52.58
52-wk Low
$28.51

CNC.N

Chart for CNC.N

About

Centene Corporation is a multi-line healthcare enterprise, which provides programs and services to the number of under-insured and uninsured individuals. The Company provides member-focused services through locally based staff by assisting in accessing care, coordinating referrals to related health and social services and... (more)

Overall

Beta: 0.85
Market Cap (Mil.): $2,828.78
Shares Outstanding (Mil.): 54.42
Dividend: --
Yield (%): --

Financials

  CNC.N Industry Sector
P/E (TTM): 5,873.45 150.86 30.65
EPS (TTM): -0.02 -- --
ROI: -0.74 0.74 18.83
ROE: 0.09 10.25 19.74
Search Stocks

Centene tops estimates on new, expanded Medicaid contracts

- Health insurer Centene Corp reported a better-than-expected quarterly profit as it added more states under its Medicaid contracts and expanded its coverage in existing ones.

23 Apr 2013

UPDATE 1-Centene tops estimates on new, expanded Medicaid contracts

April 23 - Health insurer Centene Corp reported a better-than-expected quarterly profit as it added more states under its Medicaid contracts and expanded its coverage in existing ones.

23 Apr 2013

Centene profit tops estimates on new contracts

April 23 - Health insurer Centene Corp reported a better-than-expected quarterly profit as new contracts and expansion of existing contracts boosted revenue by 53 percent.

23 Apr 2013

Centene maintains 2013 outlook; shares close up

- Health insurer Centene Corp's fourth-quarter results were hurt by a severe flu season in the United States, but the company backed its 2013 forecasts, suggesting it was on the mend after setbacks in its key markets.

05 Feb 2013

UPDATE 1-Centene maintains 2013 outlook; shares close up

* Maintains premium, service revenue view of $9.7 bln to $10 bln

05 Feb 2013

CORRECTED-Centene profit falls 70 percent on high flu costs

(Corrects to remove reference to adjusted earnings of 47 cents per share. The net profit of 17 cents per share is comparable with analysts' estimates)

05 Feb 2013

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$58.00
Provider: Datamonitor
$175.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$426.00
Provider: Stock Traders Daily
$495.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks